Literature DB >> 2629885

Monoclonal antibodies against IgG allotypes G1m(z), G1m(a), G1m(f), G3m(b1/u) and G3m(g1): their usefulness in HAI and capture ELISA.

G G de Lange1, A M van Leeuwen, A Vlug, P H van Eede, C P Engelfriet, P J Lincoln.   

Abstract

Monoclonal antibodies (McAbs) were produced against the IgG allotypes G1m(z), G1m(a), G1m(f), G3m(b1/u) and G3m(g1). Four out of the six McAbs described in this paper showed in the haemagglutination assay cross-reactivity with some or all IgG-coated cell samples. In the haemagglutination inhibition assay, all six McAbs are useful as typing reagent for the above allotypes. In this assay, two of the McAbs show two different specificities, which depend on the Ig-coated cell sample used. Five McAbs are useful for allotyping in a capture ELISA. The results with four of these are promising for the development of a quantitative determination of Gm allotypes.

Mesh:

Substances:

Year:  1989        PMID: 2629885

Source DB:  PubMed          Journal:  Exp Clin Immunogenet        ISSN: 0254-9670


  4 in total

1.  Gel test assay for IgG subclass detection by GM typing: application to hemolytic disease of the newborn.

Authors:  S J Alié-Daram; A Fournié; J M Dugoujon
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

2.  Half-life of the maternal IgG1 allotype in infants.

Authors:  H Sarvas; I Seppälä; S Kurikka; R Siegberg; O Mäkelä
Journal:  J Clin Immunol       Date:  1993-03       Impact factor: 8.317

3.  Heteroclitic polyclonal and monoclonal anti-Gm(a) and anti-Gm(g) human rheumatoid factors react with epitopes induced in Gm(a-), Gm(g-) IgG by interaction with antigen or by nonspecific aggregation. A possible mechanism for the in vivo generation of rheumatoid factors.

Authors:  R C Williams; C C Malone; P Casali
Journal:  J Immunol       Date:  1992-09-01       Impact factor: 5.422

4.  The first monoclonal anti-G1m(x) antibody: production and usefulness in haemagglutination-inhibition assay.

Authors:  G G De Lange; A M van Leeuwen
Journal:  Immunology       Date:  1991-11       Impact factor: 7.397

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.